Watchlist Price Alert

Neumora Therapeutics Inc.... (NMRA)

NASDAQ: NMRA · Real-Time Price · USD

0.79

-0.07 (-8.52%)

At close: Jun 17, 2025, 3:03 PM

Neumora Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-243.79M	-235.93M	-130.9M	-237.31M	-99.27M
Depreciation & Amortization	n/a	668K	594K	538K	105K
Stock-Based Compensation	39.99M	17.24M	8.3M	4.27M	1.68M
Other Working Capital	19.76M	-8.32M	-5.7M	-202K	1.55M
Other Non-Cash Items	-1.77M	63.64M	15.35M	158.09M	70.77M
Deferred Income Tax	n/a	n/a	-1.28M	-53K	3.08M
Change in Working Capital	22.64M	-8.9M	-6.95M	-961K	-3.12M
Operating Cash Flow	-182.94M	-163.28M	-114.9M	-75.42M	-26.76M
Capital Expenditures	n/a	-117K	-511K	-817K	-1.3M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-312.22M	-109.07M	-226.37M	n/a	n/a
Sales Maturities Of Investments	n/a	178.17M	71.87M	n/a	n/a
Other Investing Acitivies	-70.56M	-4.59M	-13M	n/a	-9.94M
Investing Cash Flow	-70.56M	64.39M	-168.01M	-817K	-11.24M
Debt Repayment	n/a	n/a	n/a	n/a	55.91M
Common Stock Repurchased	n/a	-491K	n/a	n/a	-2K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.91M	-948K	3.53M	1.37M	n/a
Financial Cash Flow	21.6M	231.94M	115.74M	293.51M	230.1M
Net Cash Flow	-231.89M	133.04M	-167.17M	217.27M	192.1M
Free Cash Flow	-182.94M	-163.4M	-115.41M	-76.24M	-28.06M